These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32734551)

  • 1. First-generation somatostatin receptor ligands and pregnancy: lesson from women with acromegaly.
    Vialon M; Grunenwald S; Mouly C; Vezzosi D; Bennet A; Caron P
    Endocrine; 2020 Nov; 70(2):396-403. PubMed ID: 32734551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs).
    Brunetti A; Antonini S; Saladino A; Lavezzi E; Zampetti B; Cozzi R
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor ligands in the treatment of acromegaly.
    Gadelha MR; Wildemberg LE; Bronstein MD; Gatto F; Ferone D
    Pituitary; 2017 Feb; 20(1):100-108. PubMed ID: 28176162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.
    Chiloiro S; Mazziotti G; Giampietro A; Bianchi A; Frara S; Mormando M; Pontecorvi A; Giustina A; De Marinis L
    Pituitary; 2018 Jun; 21(3):302-308. PubMed ID: 29397538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational diabetes and acromegaly: Single-centre experience of 14 pregnancies.
    Vialon M; Grunenwald S; Mouly C; Vezzosi D; Bennet A; Gourdy P; Caron PJ
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):805-809. PubMed ID: 31520541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
    Coopmans EC; Korevaar TIM; van Meyel SWF; Daly AF; Chanson P; Brue T; Delemer B; Hána V; Colao A; Carvalho D; Jaffrain-Rea ML; Stalla GK; Fajardo-Montañana C; Beckers A; van der Lely AJ; Petrossians P; Neggers SJCMM
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32589751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal Insulin-like Growth Factor 1 During Somatostatin Receptor Ligand Treatment Predicts Surgical Cure in Acromegaly.
    Losa M; Garbin E; Pedone E; Mortini P
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32609842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: MANAGEMENT OF ACROMEGALY PATIENTS: WHAT IS THE ROLE OF PRE-OPERATIVE MEDICAL THERAPY?
    Fleseriu M; Hoffman AR; Katznelson L;
    Endocr Pract; 2015 Jun; 21(6):668-73. PubMed ID: 26135961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
    Caron P; Broussaud S; Bertherat J; Borson-Chazot F; Brue T; Cortet-Rudelli C; Chanson P
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4680-7. PubMed ID: 20660047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression.
    Muhammad A; Coopmans EC; Gatto F; Franck SE; Janssen JAMJL; van der Lely AJ; Hofland LJ; Neggers SJCMM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):915-924. PubMed ID: 30346538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment escape reduces the effectiveness of cabergoline during long-term treatment of acromegaly in monotherapy or in association with first-generation somatostatin receptor ligands.
    Kasuki L; Dalmolin MD; Wildemberg LE; Gadelha MR
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):889-895. PubMed ID: 29520805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful pregnancy in a woman with acromegaly treated with octreotide.
    Neal JM
    Endocr Pract; 2000; 6(2):148-50. PubMed ID: 11421531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of octreotide exposure during pregnancy in acromegaly.
    Maffei P; Tamagno G; Nardelli GB; Videau C; Menegazzo C; Milan G; Calcagno A; Martini C; Vettor R; Epelbaum J; Sicolo N
    Clin Endocrinol (Oxf); 2010 May; 72(5):668-77. PubMed ID: 19769624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly.
    van der Lely AJ; Kuhn E; Muhammad A; Coopmans EC; Neggers SJ; Chanson P
    Eur J Endocrinol; 2020 Jun; 182(6):D17-D29. PubMed ID: 32234975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with somatostatin analogs does not affect the anesthesiologic management of patients with acromegaly.
    Losa M; Donofrio CA; Gemma M; Barzaghi LR; Mortini P
    Pituitary; 2019 Apr; 22(2):187-194. PubMed ID: 30826981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of combination medical therapy in the treatment of acromegaly.
    Lim DS; Fleseriu M
    Pituitary; 2017 Feb; 20(1):136-148. PubMed ID: 27522663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs.
    Chiloiro S; Giampietro A; Frara S; Bima C; Donfrancesco F; Fleseriu CM; Pontecorvi A; Giustina A; Fleseriu M; De Marinis L; Bianchi A
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31613969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider.
    Geer EB; Sisco J; Adelman DT; Ludlam WH; Haviv A; Gelbaum D; Liu S; Mathias SD; Shi L
    Pituitary; 2020 Apr; 23(2):140-148. PubMed ID: 31808101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.